IL6 and metabolic dysfunction-associated steatotic liver disease: Both models were compared for a range of biomarkers expressed in NAFLD/NASH,28 and the NASH model was found to display a pro‐inflammatory phenotype with the detection of IL‐6 secretion (Fig. 1A), TNF‐α secretion (Fig. 1B), and the expression of a range of pro‐inflammatory genes (Fig. 1C).